Control (n = 457) | COVID-19 (n = 71) | Wartime (n = 149) | P value | |
---|---|---|---|---|
Age, years | 52.1 ± 20.9 | 48.9 ± 22.2 | 51.9 ± 20.7 | P = 0.48 |
Gender | ||||
Male | 257 (56) | 42 (59%) | 92 (62%) | P = 0.48 |
Female | 200 (44%) | 29 (41%) | 57 (38%) | |
Heart failure | 58 (13%) | 9 (13%) | 29 (20%) | P = 0.11 |
Diabetes | 118 (26%) | 5 (7%) | 23 (15%) | P 1,2 <0.01 |
Kidney failure | 20 (4%) | 7 (10%) | 8 (6%) | P = 0.15 |
COPD | 43 (9.2%) | 15 (21.1%) | 23 (15.8%) | P 1,3 <0.05 |
Asthma | 43 (9.2%) | 8 (11.3%) | 24 (16.4%) | P 2 = 0.02 |
Hemoglobin | 13.2 ± 2.2 | 13.6 ± 2.3 | 13.1 ± 2.1 | P = 0.16 |
White blood cell count | 11.4 ± 3.7 | 11.5 ± 4.0 | 11.85 ± 4.30 | P = 0.41 |
CRP, median, IQR | 16.3 [4.9–57.8] | 13.4 [5.1–54.0] | 12.8 n = 2 | P = 0.58 |
Body temperature | 36.8 ± 0.37 | 36.7 ± 0.22 | 36.8 ± 0.59 | p = 0.98 |
pH | 7.37 ± 0.06 | 7.35 ± 0.05 | 7.51 n = 1 | P = 0.60 |
Heart rate | 80.0 ± 12.1 | 80.1 ± 8.9 | 81.7 ± 14.5 | P = 0.65 |
Pain, according to VAS | 6.39 ± 1.17 | 8.72 ± 0.81 | N/A | P < 0.001 |
Creatinine | 0.99 ± 0.64 | 0.89 ± 0.24 | 1.06 ± 0.42 | P = 0.15 |
BMI | 27.9 ± 5.3 | 27.7 ± 4.5 | 23.2 n = 1 | P = 0.60 |
Time from symptoms, median, IQR | 1.5 [1–3] | 3[ 1–4] | 1 [ 0.42–1.5] | P 1,2,3 <0.001 |
Treatment | P 1,2 <0.001 | |||
Surgery | 166 % (36%) | 45 (63%) | 93 (63%) | P = 1.00 |
Invasive | 9 (2%) | 0 | 3 (2%) | P = 1.00 |
Invasive and conservative | 10 (2%) | 0 | 4 (3%) | *P 1 = 0.0004 |
Conservative | *272 (60%) | *26 (37%) | 48 (32%) | P 2 < 0.0001 |
Dementia (cognitive status) | 23 (5%) | 8 (11.3%) | 10 (6.7%) | P = 0.054 |